Pericytes from human veins for treatment of myocardial ischemia

Trends in Cardiovascular Medicine

Volumn 23, Issue 3, 2013, Pages 66-70

  Katare, Rajesh G ^a   Madeddu, Paolo ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; AORTA; CELL REGENERATION; CELL SURVIVAL; FIBROSING ALVEOLITIS; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; LEG VEIN; NONHUMAN; PERICYTE; PRIORITY JOURNAL; REVIEW; TOPOGRAPHY;

ANIMALS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FIBROSIS; HUMANS; LOWER EXTREMITY; MICE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PERICYTES; REGENERATION; VEINS;

EID: 84875249915     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.09.002     Document Type: Review

References (24)

1. Alessandri G., Girelli M., Taccagni G., Colombo A., Nicosia R., Caruso A., et al. Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Laboratory Investigation 2001, 81:875-885.
2. Anand S., Majeti B.K., Acevedo L.M., Murphy E.A., Mukthavaram R., Scheppke L., et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nature Medicine 2010, 16:909-914.
3. Barcelos L.S., Duplaa C., Kränkel N., Graiani G., Invernici G., Katare R., et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signalling. Circulation Research 2009, 104:1095-1102.
4. Behfar A., Faustino R.S., Arrell D.K., Dzeja P.P., Perez-Terzic C., Terzic A. Guided stem cell cardiopoiesis: discovery and translation. Journal of Molecular and Cellular Cardiology 2008, 45:523-529.
5. Belch J., Hiatt W.R., Baumgartner I., Driver IV, Nikol S, Norgren L, Van Belle E; TAMARIS Committees and Investigators. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011, 377:1929-1937.
6. Burchfield J.S., Dimmeler S. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair 2008, 1:1-11.
7. Campagnolo P., Cesselli D., Al Haj Zen A., Beltrami A.P., Kränkel N., Katare R., et al. Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 2010, 121:1735-1745.
8. Chavakis E., Koyanagi M., Dimmeler S. Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. Circulation 2010, 121:325-335.
9. Corselli M., Chen C.W., Crisan M., Lazzari L., Péault B. Perivascular ancestors of adult multipotent stem cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30:1104-1109.
10. Creager M.A., Olin J.W., Belch J.J., et al. Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Circulation 2011, 124:1765-1773.
11. Crisan M., Chen C.W., Corselli M., Andriolo G., Lazzari L., Péault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 11:301-313.
12. De Angelis L., Berghella L., Coletta M., Lattanzi L., Zanchi M., Cusella-De Angelis M.G., et al. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. Journal of Cell Biology 1999, 147:869-878.
13. Dimmeler S., Zeiher A.M., Schneider M.D. Unchain my heart: the scientific foundations of cardiac repair. Journal of Clinical Investigation 2005, 115:572-583.
14. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research 2008, 103:1204-1219.
15. Gupta R., Tongers J., Losordo D.W. Human studies of angiogenic gene therapy. Circulation Research 2009, 105:724-736.
16. Hirschi K.K., D'Amore P.A. Pericytes in the microvasculature. Cardiovascular Research 1996, 32:687-698.
17. Invernici G., Emanueli C., Madeddu P., Cristini S., Gadau S., Benetti A., et al. Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. American Journal of Pathology 2007, 170:1879-1892.
18. Isner J.M., Pieczek A., Schainfeld R., et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 1996, 348:370-374.
19. Jin W., Reddy M.A., Chen Z., Putta S., Lanting L., Kato M., et al. Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. Journal of Biological Chemistry 2012, 287:15672-15683.
20. Katare R., Riu F., Mitchell K., Gubernator M., Campagnolo P., Cui Y., et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circulation Research 2011, 109:894-906.
21. Loffredo F.S., Steinhauser M.L., Gannon J., Lee R.T. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011, 8:389-398.
22. Mackie A., Losordo D. CD34-positive stem cells in the treatment of heart and vascular disease in human beings. Texas Heart Institute Journal 2011, 38:474-485.
23. Mann J., Chu D.C., Maxwell A., Oakley F., Zhu N.L., Tsukamoto H., et al. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 2010, 138:705-714.
24. Martin-Rendon E., Brunskill S.J., Hyde C.J., Stanworth S.J., Mathur A., Watt S.M. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. European Heart Journal 2008, 29:1807-1818.